Jeffrey T. Guptill

Disease Area Development Lead - Neuromuscular, Clinical Development, argenx

Jeffrey T. Guptill is listed as Disease Area Development Lead - Neuromuscular, Clinical Development, argenx. Jeffrey spoke at DGN Kongress 2026 (Kongress der Deutschen Gesellschaft für Neurologie) in November 2026 (speaker, “Neuroimmunologie III”).

Compiled from published conference agendas; not yet confirmed by Jeffrey. Is this you? Claim this profile.

Sessions at 1 conference